294 related articles for article (PubMed ID: 35816877)
1. Seeking heterocyclic scaffolds as antivirals against dengue virus.
De S; Aamna B; Sahu R; Parida S; Behera SK; Dan AK
Eur J Med Chem; 2022 Oct; 240():114576. PubMed ID: 35816877
[TBL] [Abstract][Full Text] [Related]
2. Anti-DENV and Anti-Dengue Vector Activity of Some Heterocyclic Scaffolds.
Purohit D; Dhingra N; Dutt R; Kumar S
Mini Rev Med Chem; 2020; 20(12):1062-1071. PubMed ID: 32286943
[TBL] [Abstract][Full Text] [Related]
3. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
J Virol; 2017 May; 91(10):. PubMed ID: 28298600
[TBL] [Abstract][Full Text] [Related]
4. Infection of Aedes albopictus Mosquito C6/36 Cells with the
Teramoto T; Huang X; Armbruster PA; Padmanabhan R
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092581
[TBL] [Abstract][Full Text] [Related]
5. Melatonin Inhibits Dengue Virus Infection via the Sirtuin 1-Mediated Interferon Pathway.
Morchang A; Malakar S; Poonudom K; Noisakran S; Yenchitsomanus PT; Limjindaporn T
Viruses; 2021 Apr; 13(4):. PubMed ID: 33920458
[TBL] [Abstract][Full Text] [Related]
6. Prohemocytes are the main cells infected by dengue virus in Aedes aegypti and Aedes albopictus.
Cheng L; Liu WL; Su MP; Huang SC; Wang JR; Chen CH
Parasit Vectors; 2022 Apr; 15(1):137. PubMed ID: 35449113
[TBL] [Abstract][Full Text] [Related]
7. In-vitro antiviral action of Eupatorium perfoliatum against dengue virus infection: Modulation of mTOR signaling and autophagy.
Sinha M; Chakraborty U; Kool A; Chakravarti M; Das S; Ghosh S; Thakur L; Khuranna A; Nayak D; Basu B; Kar S; Ray R; Das S
J Ethnopharmacol; 2022 Jan; 282():114627. PubMed ID: 34509603
[TBL] [Abstract][Full Text] [Related]
8. Blood glucose promotes dengue virus infection in the mosquito Aedes aegypti.
Weng SC; Tsao PN; Shiao SH
Parasit Vectors; 2021 Jul; 14(1):376. PubMed ID: 34311776
[TBL] [Abstract][Full Text] [Related]
9. Transmission Potential of Floridian Aedes aegypti Mosquitoes for Dengue Virus Serotype 4: Implications for Estimating Local Dengue Risk.
Stephenson CJ; Coatsworth H; Kang S; Lednicky JA; Dinglasan RR
mSphere; 2021 Aug; 6(4):e0027121. PubMed ID: 34232077
[TBL] [Abstract][Full Text] [Related]
10. Revisiting dengue virus-mosquito interactions: molecular insights into viral fitness.
Siriphanitchakorn T; Kini RM; Ooi EE; Choy MM
J Gen Virol; 2021 Nov; 102(11):. PubMed ID: 34845981
[TBL] [Abstract][Full Text] [Related]
11. Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus.
Anasir MI; Ramanathan B; Poh CL
Viruses; 2020 Mar; 12(4):. PubMed ID: 32225021
[TBL] [Abstract][Full Text] [Related]
12. Management and Treatment of Dengue and Chikungunya - Natural Products to the Rescue.
Suroowan S; Mahomoodally F; Ragoo L
Comb Chem High Throughput Screen; 2016; 19(7):554-64. PubMed ID: 27151484
[TBL] [Abstract][Full Text] [Related]
13. Control of dengue virus in the midgut of Aedes aegypti by ectopic expression of the dsRNA-binding protein Loqs2.
Olmo RP; Ferreira AGA; Izidoro-Toledo TC; Aguiar ERGR; de Faria IJS; de Souza KPR; Osório KP; Kuhn L; Hammann P; de Andrade EG; Todjro YM; Rocha MN; Leite THJF; Amadou SCG; Armache JN; Paro S; de Oliveira CD; Carvalho FD; Moreira LA; Marois E; Imler JL; Marques JT
Nat Microbiol; 2018 Dec; 3(12):1385-1393. PubMed ID: 30374169
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of four types of bioflavonoid against dengue virus type-2.
Zandi K; Teoh BT; Sam SS; Wong PF; Mustafa MR; Abubakar S
Virol J; 2011 Dec; 8():560. PubMed ID: 22201648
[TBL] [Abstract][Full Text] [Related]
15. Wolbachia-Based Dengue Virus Inhibition Is Not Tissue-Specific in Aedes aegypti.
Amuzu HE; McGraw EA
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005145. PubMed ID: 27855218
[TBL] [Abstract][Full Text] [Related]
16. Activation of the autophagy pathway decreases dengue virus infection in Aedes aegypti cells.
Chen TY; Smartt CT
Parasit Vectors; 2021 Oct; 14(1):551. PubMed ID: 34702321
[TBL] [Abstract][Full Text] [Related]
17. Antivirus effectiveness of ivermectin on dengue virus type 2 in Aedes albopictus.
Xu TL; Han Y; Liu W; Pang XY; Zheng B; Zhang Y; Zhou XN
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006934. PubMed ID: 30452439
[TBL] [Abstract][Full Text] [Related]
18. Vertical transmission of dengue virus in Aedes aegypti and its role in the epidemiological persistence of dengue in Central and Southern Mexico.
Danis-Lozano R; Díaz-González EE; Malo-García IR; Rodríguez MH; Ramos-Castañeda J; Juárez-Palma L; Ramos C; López-Ordóñez T; Mosso-González C; Fernández-Salas I
Trop Med Int Health; 2019 Nov; 24(11):1311-1319. PubMed ID: 31483936
[TBL] [Abstract][Full Text] [Related]
19. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles in the fight against mosquito-borne diseases: bioactivity of Bruguiera cylindrica-synthesized nanoparticles against dengue virus DEN-2 (in vitro) and its mosquito vector Aedes aegypti (Diptera: Culicidae).
Murugan K; Dinesh D; Paulpandi M; Althbyani AD; Subramaniam J; Madhiyazhagan P; Wang L; Suresh U; Kumar PM; Mohan J; Rajaganesh R; Wei H; Kalimuthu K; Parajulee MN; Mehlhorn H; Benelli G
Parasitol Res; 2015 Dec; 114(12):4349-61. PubMed ID: 26290219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
